Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
8.78
+0.65 (8.00%)
Dec 20, 2024, 4:00 PM EST - Market closed

Sera Prognostics Revenue

Sera Prognostics had revenue of $29.00K in the quarter ending September 30, 2024, a decrease of -30.95%. This brings the company's revenue in the last twelve months to $94.00K, down -71.52% year-over-year. In the year 2023, Sera Prognostics had annual revenue of $306.00K with 14.18% growth.

Revenue (ttm)
$94.00K
Revenue Growth
-71.52%
P/S Ratio
n/a
Revenue / Employee
$1,649
Employees
57
Market Cap
296.52M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023306.00K38.00K14.18%
Dec 31, 2022268.00K186.00K226.83%
Dec 31, 202182.00K57.00K228.00%
Dec 31, 202025.00K-11.00K-30.56%
Dec 31, 201936.00K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Procaps Group 414.10M
OraSure Technologies 224.26M
Amylyx Pharmaceuticals 196.49M
Zynex 193.67M
Vanda Pharmaceuticals 190.86M
Sanara MedTech 78.06M
C4 Therapeutics 33.67M
Foghorn Therapeutics 25.52M
Revenue Rankings